5Karen BG,Roy Ls.Hypercoagulability in cancer[J].Hematol Oncol North Am,1996,10(2):449. 被引量：1
6Mannel,Polo P.Venous thromboembolism as first manifestation of cancer[ J].Seminars in thrombosis and hemastasis,1999,25(2):131. 被引量：1
7Polo P,Andrea P,Antonio G.Cancer and venous thromboembolism An Overview[J].Heamatologica,1999,84(2):437. 被引量：1
8AnnaF,Frederick RR.Pathophysiology of the thrombophilic state in the cancer patient[ J ].Seminars in thrombosis and hemostasis.1999,25(2):173. 被引量：1
9Falanga A,Cosonni R,Marchetti,et al.Cancer procoagulant and tissue factor are differently modulated by all-transretinoic acid (ATRA) in acute promyelocytic leukemia cells[ J ].Blood,1998,92 (3):143. 被引量：1
10贾汝汉主编..内科疾病治疗学[M].武汉:湖北科学技术出版社,2003:1057.
二级参考文献11
1[1]Karen BG, Roy LS. Hypercoagulability in cancer. Hematoi Oncol Clin North Am, 1996; 10(2) :499. 被引量：1
2[2]Manuel M, Paolo P. Venous thromboembolism as first manifestation of cancer. Seminars in Thrombosis and Hemastasis, 1999, 25 (2):131. 被引量：1
3[3]Monreal M, Lafoz E, Casals, et al. Occult cancer in patients with deep venous thrombosis: a systematic approach. Cancer, 1991,67: 541. 被引量：1
4[4]Piccioli A, Prandoni P, Ewenstein BM, et al. Cancer and venous thromboembolism. Am Heart J, 1996. 132:850. 被引量：1
5[5]Anna, F, Frederick RR, Pathophysiology of the thrombophilic state in the cancer patient. Seminars in Thrombosis and Hemostasis 1999,25(2): 173. 被引量：1
6[6]John LF, John B, Ali A. Hemostasis and malignancy. Seminars in Thrombosis and Hemostasis, 1998,24 (2): 93. 被引量：1
7[7]Paolo P, Andrea P, Antonio G, Cancer and venous thromboembolism: An overview. Haematologica, 1999,84: 437. 被引量：1
8[8]Falanga A, Consonni R, Marchetti M, et al. Cancer procoagulant and tissue factor are differently modulated by all-trans-retinoic acid ( ATRA) in acute promyelocytic leukemia cells. Blood, 1998,92: 143. 被引量：1
9[9]Shoji M, Hancock WW, Abe K, et al. Activation of coagulattion and angiogenesis in cancer. Immunohistochemical localization in situ of clotting proteins and VEGF in human cancers. Am J Pathol, 1998,152:399. 被引量：1
10[10]Agnes YYL, Mark NL. The thrombophilic state induced by therapeutic agents in the cancer patient. Seminars in Thrombosis and Hemostasis, 1999,25 (2): 137. 被引量：1
4Polo P, Andrea P, Antonio G.Cancer and venous throm-boembolism an overview [J]. Heamatologica, 1999, 84 (2) : 437. 被引量：1
5M Ogren, D Bergqvist, H Erisksson, et al. Prevalence and risk of pulmonary embolism in patients with intracardiac thrombosis: a population based study of 23796 consecutive autopsies[ J]. Eur Heart J, 2005,26( 11 ) : 1108. 被引量：1
6Goldhaber SZ,Visani L, Rosa M.Acute pulmonary embolism: Clinical outcomes in the international cooperative pulmonary embolism registry[J]. Lancer, 1999,353(3) : 1386. 被引量：1
8Castoldi E,Maurissen LF,Tormene D et al.Similar hypercoagulable state and thrombosis risk in type I and type III protein Sdeficient individuals from families with mixed type I/III protein S deficiency[J].Haematologica,2010,95:1563-1571. 被引量：1
9Pineda MC,Lopinto-KhouryC.Cerebral venous sinus thrombosis secondary to typhoid fever:a case report and brief summary of the literature[J].The Neurologist,2012,18:202-203. 被引量：1
